Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Obstructive Cardiomyopathy, Hypertrophic”

133 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 133 results

Not applicableLooking for participantsNCT04265040
What this trial is testing

DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies

Who this might be right for
Non-ischemic CardiomyopathyDCM - Dilated CardiomyopathyHCM - Hypertrophic Cardiomyopathy+5 more
University Hospital Heidelberg 2,040
Not applicableNot Yet RecruitingNCT07408427
What this trial is testing

Precision Pharmacogenetics and Genotype Class Based Prediction of Mavacamten Response in Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
University of Manchester 140
Not applicableLooking for participantsNCT06146660
What this trial is testing

Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb 600
Not applicableStudy completedNCT01729702
What this trial is testing

Neurohormonal Parameters in Hypertrophic Cardiomyopathies

Who this might be right for
1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy2- Obstructive Hypertrophic Cardiomyopathy3- Non Obstructive Hypertrophic Cardiomyopathy
French Cardiology Society 131
Post-approval studies (Phase 4)Looking for participantsNCT07004972
What this trial is testing

Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

Who this might be right for
Symptomatic Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb 50
Large-scale testing (Phase 3)Study completedNCT04349072
What this trial is testing

Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy

Who this might be right for
HOCM, Hypertrophic Obstructive Cardiomyopathy
Bristol-Myers Squibb 112
Not applicableStudy completedNCT04686487
What this trial is testing

SterEotactic AbLative Radiotherapy in PatiEnts With HypertrophiC ObstrucTive Cardiomyopathy

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy
Second Xiangya Hospital of Central South University 5
Not applicableStudy completedNCT06609382
What this trial is testing

Left Ventricular Mass Index Predicts Clinical Outcomes in Patients with Obstructive Hypertrophic Cardiomyopathy Undergoing Septal Myectomy

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Changrong Nie 490
Not applicableActive Not RecruitingNCT07003945
What this trial is testing

Clinical Outcomes of PIMSRA Treating for Hypertrophic Obstructive Cardiomyopathy: A Large-Sample Study

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy (HOCM)
Xijing Hospital 800
Not applicableUnknownNCT05771987
What this trial is testing

Permanent Pacing for Drug-refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
Istituto Auxologico Italiano 10
Not applicableUnknownNCT04275544
What this trial is testing

Risk Factors of Postoperative Complications in HCM Patients

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy
Xijing Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00035386
What this trial is testing

Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study

Who this might be right for
Hypertrophic Cardiomyopathy
National Heart, Lung, and Blood Institute (NHLBI) 12
Large-scale testing (Phase 3)Study completedNCT05414175
What this trial is testing

Mavacamten in Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Cardiomyopathy, Hypertrophic Obstructive
Bristol-Myers Squibb 38
Not applicableUnknownNCT06211595
What this trial is testing

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
Hangzhou Valgen Medtech Co., Ltd 10
Testing effectiveness (Phase 2)Study completedNCT03442764
What this trial is testing

Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
MyoKardia, Inc. 59
Not applicableUnknownNCT06003478
What this trial is testing

The Safety and Influencing Factors of Liwen Procedure in The Treatment of Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Obstructive Cardiomyopathy
Xijing Hospital 486
Not applicableActive Not RecruitingNCT06372457
What this trial is testing

COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
Bristol-Myers Squibb 500
Large-scale testing (Phase 3)Looking for participantsNCT06481891
What this trial is testing

Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Cardiomyopathy, HypertrophicNon-obstructive Hypertrophic Cardiomyopathy
Lexicon Pharmaceuticals 500
Testing effectiveness (Phase 2)UnknownNCT00430833
What this trial is testing

CHANCE - Candesartan in Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Charles University, Czech Republic
Large-scale testing (Phase 3)Active Not RecruitingNCT06081894
What this trial is testing

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

Who this might be right for
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Cytokinetics 500
Load More Results